Worth a closer look
- Open-market purchase with their own money (Form 4 code P), not a grant or option exercise.
- Raised their own holding by 48%.
- 3 different insiders bought in the last 90 days.
Reasons for caution
- Other insiders sold $3.7M in the same 90 days, more than was bought.
- Similar past buys beat the S&P 500 only 35% of the time (86 cases); the typical one trailed it by 7.0%.
What happened after this filing
Insider Twins: past buys with the same traits
2 insiders buying · incl. CEO or CFO · $1M+ · stock down 0–20% in 3 months
PGNY Dec 26, 2024 +53.6% vs S&PMEDP Sep 23, 2022 +41.4% vs S&PADT Mar 8, 2021 +34.6% vs S&PDRVN May 30, 2023 -44.8% vs S&PAVPT Sep 2, 2021 -36.1% vs S&PABCL Nov 15, 2021 -35.7% vs S&PWhat we couldn't check
- Why they traded. Filings don't say, and we don't guess.
- Company news after the filing, and any private terms.
Wajid Ali (a director) bought $902K of TTMI at about $90.25 on Oct 28, 2026, reported to the SEC on Oct 28, 2026. Buys like this beat the S&P 500 35% of the time since 2020, against 46% for all insider buys. We found 3 points that make it worth a closer look and 2 reasons for caution. History, not a prediction.
Following. We'll keep this page updated; see everything you follow. Want an email when the 30 and 90-day results land? Use the TTMI alerts below.
Written by fixed rules from SEC filings and our measured history, not by an AI model. Public data only. History, not a prediction, and not investment advice.